Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Gynecological Tumors.

RecruitingOBSERVATIONAL
Enrollment

380

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

December 27, 2024

Study Completion Date

December 27, 2024

Conditions
Gynecological Tumors
Interventions
DIAGNOSTIC_TEST

the diagnostic and prognostic value of PET/MRI and PET/CT with 18F-FDG in patients presenting with gynecological tumors

"For the evaluation of patients affected by endometrial cancer, the correlations between semi-quantitative PET parameters (SUVmax, SUVmean, MTV and TLG calculated at different SUVmax thresholds) and histological data, such as for example myometrial invasion, will be investigated. lymph node invasion, tumor grade and type, risk level, probability of mutation of the p53 gene, etc.~In addition to traditional imaging parameters we will also investigate the usefulness of radiomic features, i.e. quantitative data extracted from PET images (PET/CT or PET/MRI), in predicting and explaining histological data"

Trial Locations (1)

Unknown

RECRUITING

Irccs San Raffaele, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER